tralokinumab
Brand: ADBRY
approved
Quick answer
tralokinumab (ADBRY), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- tralokinumab
- Brand
- ADBRY
- Route
- INJECTION
- Formulation
- INJECTABLE
Frequently asked questions
What is tralokinumab?
tralokinumab (ADBRY), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for tralokinumab?
ADBRY is a marketed brand name for tralokinumab. Check FDA Drugs@FDA for the current US label holder.